| 000 | 01647 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513091043.0 | ||
| 264 | 0 | _c19960717 | |
| 008 | 199607s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/(SICI)1097-0142(19960615)77:12<2560::AID-CNCR20>3.0.CO;2-P _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGalligioni, E | |
| 245 | 0 | 0 |
_aAdjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study. _h[electronic resource] |
| 260 |
_bCancer _cJun 1996 |
||
| 300 |
_a2560-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBCG Vaccine _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _ximmunology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity, Delayed _ximmunology |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aKidney Neoplasms _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aQuaia, M | |
| 700 | 1 | _aMerlo, A | |
| 700 | 1 | _aCarbone, A | |
| 700 | 1 | _aSpada, A | |
| 700 | 1 | _aFavaro, D | |
| 700 | 1 | _aSantarosa, M | |
| 700 | 1 | _aSacco, C | |
| 700 | 1 | _aTalamini, R | |
| 773 | 0 |
_tCancer _gvol. 77 _gno. 12 _gp. 2560-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1097-0142(19960615)77:12<2560::AID-CNCR20>3.0.CO;2-P _zAvailable from publisher's website |
| 999 |
_c8639744 _d8639744 |
||